drugset / Trial / NCT02720445

Memory Improvement Through Nicotine Dosing (MIND) Study

NCT02720445

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to see if daily transdermal nicotine is able to produce a significant cognitive, clinical and functional improvement in participants with MCI. Neuronal nicotinic receptors have long been known to play a critical role in memory function in preclinical studies, with nicotine improving attention, learning, and memory function. The study will enroll 380 participants for a 2 year period. Participants will be randomized (50:50) to either the transdermal nicotine, beginning at 7mg/day, and increasing to 21mg/day, or placebo skin patch.

Timeline

Start
2017-01-13
Primary completion
2025-08-25
Completion
2025-09-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 21 mg Other